Virginie Verkarre

Inserm — France

Medicine · Health Sciences

56h-index14.6kcitations447works0.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Renal cell carcinoma treatment(227), Renal and related cancers(115), Cancer Immunotherapy and Biomarkers(94), Bladder and Urothelial Cancer Treatments(47), Cancer Genomics and Diagnostics(47)

Publications447 total

Figure S1 from An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas
2025Open Access
Supplementary Tables TS1-23 from An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas
2025Open Access
Figure S4 from An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas
2025Open Access
Figure S8 from An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas
2025Open Access
Figure S6 from An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas
2025Open Access
Figure S3 from An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas
2025Open Access
Figure S5 from An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas
2025Open Access
Figure S2 from An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas
2025Open Access
Figure S7 from An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas
2025Open Access
Table S2 from Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
2025Open Access
Table S1 from Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
2025Open Access
Supplementary Figure Annotations from Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
2025Open Access
Table S3 from Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
2025Open Access
Supplementary Figures from Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
2025Open Access
Table S4 from Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
2025Open Access
Heart allograft rejection: molecular diagnosis using intra-graft targeted gene expression profiling
European Heart Journal·2025· 3 cited
457 GABA promotes resistance to immunotherapy of patients with TLS-positive tumours
Regular and Young Investigator Award Abstracts·2025Open Access
Epigenetic signatures on plasma cell-free DNA to detect kidney allograft rejection in a non-invasive way: development of a 10-plex digital PCR assay
Biomarker Research·2025· 1 citedOpen Access
Unusual bone marrow metastasis revealed by recurrent haematuria
Annales de biologie clinique·2025
Diagnostic Value of Contrast-Enhanced Ultrasound in Renal Masses Remaining Indeterminate After Contrast-Enhanced CT and Contrast-Enhanced MRI
Investigative Radiology·2025· 1 cited
page 1 of 23Next →

Frequent Co-authors

Christophe Cellier(13), Nadine Cerf–Bensussan(13), Arnaud Méjean(12), Stéphane Oudard(12), Wolf H. Fridman(10), Nicole Brousse(10), Catherine Sautès‐Fridman(9), Olivier Hermine(9), Georgia Malamut(8), Elizabeth Macintyre(7), Jacques Rahier(7), Yann Vano(6), Bertrand Meresse(6), Françis Brunelle(6), Claire Nihoul‐Feketé(6), Xavier Cathelineau(5), Diane Damotte(5), Anaïs Vallet‐Pichard(4), Stanislas Pol(4), Étienne Becht(4)